Our previous research shows that SDC1 expression in human glioma correlates with advanced tumor progression and poor prognosis, and SDC1 knockdown inhibits glioma cell proliferation and invasion by deregulating a c-src/FAK-associated signaling pathway (Shi et al., 2017). Here, PTK2 is linked to glioma.